FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/02/017811 [Registered on: 25/02/2019] Trial Registered Prospectively
Last Modified On: 14/02/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   To know which drug out of the two ( morphine and burprenorphine) used for spinal anesthesia has better pain relief in patients after surgeries of below the umblicus 
Scientific Title of Study   Comparative effects of Buprenorphine and Morphine as adjuvants to Bupivacaine spinal anesthesia in patients undergoing infra-umbilical surgeries - A Prospective study  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Hemamalini Arun 
Designation  Secondary DNB PG 
Affiliation  Sri Ramakrishna hospital , Coimbatore 
Address  Dr Hemamalini Arun ,Secondary dnb pg, dept of anaesthesiology, Sri Ramakrishna hospital, sidhapuddur, Coimbatore
Dr Hemamalini Arun , Secondary dnb pg, dept of anaesthesiology, Sri Ramakrishna hospital, Sidhapuddur, Coimbatore
Coimbatore
TAMIL NADU
641044
India 
Phone  9789875443  
Fax    
Email  dr.s.hemamalini@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Prabha Udayakumar 
Designation  Head of Department, Anesthesiology 
Affiliation  Sri Ramakrishna hospital , Coimbatore 
Address  Dept of Anesthesiology, Sri Ramakrishna hospital, Sidhapuddur, Coimbatore

Coimbatore
TAMIL NADU
641044
India 
Phone  9791346959  
Fax    
Email  prabhadr01@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Hemamalini Arun 
Designation  Secondary DNB PG 
Affiliation  Sri Ramakrishna hospital , Coimbatore 
Address  Dr Hemamalini Arun, Secondary dnb pg, dept of anaesthesiology, Sri Ramakrishna hospital, sidhapuddur Coimbatore
Dr Hemamalini Arun , Secondary dnb pg, dept of anaesthesiology, Sri Ramakrishna hospital, Sidhapuddur, Coimbatore
Coimbatore
TAMIL NADU
641044
India 
Phone  9789875443  
Fax    
Email  dr.s.hemamalini@gmail.com  
 
Source of Monetary or Material Support  
Sri Ramakrishna hospital, Coimbatore  
 
Primary Sponsor  
Name  Sri Ramakrishna hospital  
Address  Dept of Anesthesiology, Sri Ramakrishna hospital, sidhapuddur, Coimbatore  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Hemamalini Arun  Sri Ramakrishna hospital  Department of anaesthesiology, old block, Sri Ramakrishna hospital, sidhapuddur, Coimbatore
Coimbatore
TAMIL NADU 
9789875443

dr.s.hemamalini@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SRIRAMAKRISHNAHOSPITALETHICALCOMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G890||Central pain syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group B  2.8ml of 0.5% heavy bupivacaine with 60 mcg buprenorphine intrathecally 
Intervention  Group M  2.8ml of 0.5%heavy bupivacaine with 100 mcg of morphine intrathecal 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA Physical status 1 or 2
Presenting for infraumblical surgeries
Patients who provide consent for the study 
 
ExclusionCriteria 
Details  Patient allergic to the drug
ASA Physical status 3 and above , acute or chronic respiratory disease, cognitive or psychiatric disturbances
Any contraindication to subarachnoid block
Pregnant women
Day care procedures
Patients who do not give consent  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To compare the duration of postoperative analgesia of buprenorphine and morphine when given intrathecally with hyperbaric bupivacaine  2, 4, 8, 12, 24 hours of postoperative analgesia 
 
Secondary Outcome  
Outcome  TimePoints 
Time taken to achieve maximum sensory and motor block
Intraoperative hemodynamic changes like bradycardia and hypotension and intraoperative side effects like nausea, vomiting and pruritis 
Sensory and motor block will be assessed every 2 minutes till maximum level is reached 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/03/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Postoperative analgesia is generally the domain of the anaesthesiologist.Intrathecal morphing has been considered as the most effective opioid because of its potency and prolonged duration of action.Buprenorphine intrathecally also provides good postoperative pain relief without prolonging motor or sensory blockade. Hence, this study is designed to compare the effects of Buprenorphine and Morphine as adjuvants to Bupivacaine spinal anesthesia  in patients undergoing infraumblical surgeries. This is a prospective study involving 30 patients in each group. Group B will receive 2.8ml of 0.5% hyperbaric bupivacaine with Buprenorphine 60mcg while, Group M will receive 2.8 ml of 0.5% hyperbaric bupivacaine with 100 mcg of Morphine. Time to first rescue analgesia is the primary objective and secondary objectives include time taken to acheive maximum sensory and motor blockade, vital parameters, adverse effects perioperatively. 
Close